Establishment, value assignment, and characterization of new WHO reference reagents for six molecular forms of human chorionic gonadotropin

Clinical Chemistry

Volumn 51, Issue 1, 2005, Pages 177-182

  Bristow, Adrian ^a   Berger, Peter ^b   Bidart, Jean Michel ^c   Birken, Steven ^d   Norman, Robert ^e   Stenman, Ulf Håkan ^f   Sturgeon, Catharine ^g  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d Coll Phys/Surgs Columbia Univ ^*  (United States)

^e UNIVERSITY OF ADELAIDE   (Australia)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN ALPHA SUBUNIT; CHORIONIC GONADOTROPIN BETA SUBUNIT; GLYCOPROTEIN; REAGENT;

AMPOULE; ARTICLE; CALIBRATION; CONCENTRATION (PARAMETERS); DEGRADATION; FREEZE DRYING; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; NOMENCLATURE; ORGANIZATION; PURIFICATION; STANDARD; WORLD HEALTH ORGANIZATION;

CHORIONIC GONADOTROPIN; HUMANS; IMMUNOASSAY; PROTEIN SUBUNITS; REFERENCE STANDARDS; TERMINOLOGY; WORLD HEALTH ORGANIZATION;

EID: 11144348654     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.038679     Document Type: Article

References (18)

1. Stenman UH, Bidart JM, Birken S, Mann K, Nisula B, O'Connor J. Standardization of protein immunoprocedures. Choriogonadotropin (CG). Scand J Clin Lab Invest Suppl 1993;216:42-78.
2. Berger P, Sturgeon CM, Bidart JM, Paus E, Gerth R, Niang M, et al. The ISOBM TD-7 Workshop on hCG and Related Molecules. Towards user-oriented standardization of pregnancy- and tumor marker diagnosis: assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies (mAbs) directed against human chorionic gonadotropin (hCG) and derivatives. Tumor Biol 2002;23:1-38.
3. Thienpoint LM, Van Uytfanghe K, De Leenheer AP. Reference measurement systems in clinical chemistry. Clin Chim Acta 2002; 323:73-87.
4. Lapthorn AJ, Harris DC, Littlejohn A, Lustbader JW, Canfield RE, Machin KJ, et al. Crystal structure of human chorionic gonadotropin. Nature 1994;369:455-61.
5. Lottersberger C, Hoermann R, Mann K, Schwarz S, Berger P. Tumor- and pregnancy-derived isoforms of human chorionic gonadotropin: biological and diagnostic relevance. Horm Res 2003;59: 125-34.
6. Sturgeon C, Stenman UH, Birken S, Berger P, Lequin RM, Norman RJ, et al. IFCC Working Group on standardization of human chorionic gonadotropin measurements: progress report. Proceedings UK NEQAS Meeting 1998;3:134-9.
7. National Committee for Clinical Laboratory Standards. Choriogonadotropin testing: nomenclature, reference preparations, assay performance, and clinical application; approved guideline. NCCLS Document I/LA10-A. Wayne, PA: NCCLS, 1996.
8. Storring PL, Gaines-Das RE, Bangham DR. International Reference Preparation of Human Chorionic Gonadotropin for Immunoassay: potency estimates in various bioassay and protein binding assay systems; and International Reference Preparations of the α and β subunits of human chorionic gonadotropin for immunoassay. J Endocrinol 1980;84:295-310.
9. Sturgeon CM, McAllister EJ. Analysis of hCG-clinical applications and assay requirements. Ann Clin Biochem 1998;35:460-91.
10. Birken S, Berger P, Bidart JM, Weber M, Bristow A, Norman R, et al. Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites. Clin Chem 2003;49:144-54.
11. World Health Organization. Guidelines for the preparation, characterization and establishment of international and other standards and reference reagents for biological substances. WHO Tech Rep Ser 1990;800:181-213.
12. Kirkwood TBL. Predicting the stability of biological standards and products. Biometrics 1977;33:736-42.
13. Mire-Sluis AR, Das RG, Thorpe R. The International Standard for granulocyte colony stimulating factor (G-CSF). Evaluation in an International Collaborative Study. J Immunol Methods 1995;179: 117-26.
14. Page C, Dawson P, Woollacott D, Thorpe R, Mire-Sluis A. Development of a lyophilization formulation that preserves the biological activity of the platelet-inducing cytokine interleukin-11 at low concentrations. J Pharm Pharmacol 2000;52:19-26.
15. World Health Organization. 51st meeting of WHO Expert Committee on Biological Standardization. November 2001. WHO Tech Rep Ser 2004;924:in press.
16. Elliott MM, Kardana A, Lustbader JW, Cole LA. Carbohydrate and peptide structure of the α- and β-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine J 1997;7:15-32.
17. Müller MM. Implementation of reference systems in laboratory medicine. Clin Chem 2000;46:1907-9.
18. Stenman UH. Standardization of assays for human chorionic gonadotropin. Clin Chem 2004;50:798-800.